Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
MERIT-2: CPL-01 for Post-Op Pain after Bunionectomy
NCT05411861Phase 2Completed
- Sponsor
- Cali Pharmaceuticals
- Start
- Jun 2022
- Primary completion
- Sep 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of CPL-01 in postoperative pain (3 arms), sponsored by Cali Pharmaceuticals. Primary endpoint: Area Under the Curve of Pain Intensity Scores at 72 hours. Started Jun 2022; status: completed.
02
Drugs
CPL-01
03
Conditions
postoperative pain
Beyond the preview
Go deeper on NCT05411861.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05411861.